Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Must Reads In FDA Actions

FDA Actions for January/February 2018

FDA Approves Steglatro for Adults with T2D, Pfizer news release; 2017 Dec 22

More must reads

FDA Actions for November/December 2017

FDA Approves Ozempic for Treatment of T2D, Novo Nordisk news release; 2017 Dec 5

FDA Approves Epinephrine Autoinjector for Infants, Kaléo news release; 2017 Nov 20

FDA Approves Fasenra for Severe Eosinophilic Asthma, AstraZeneca news release; 2017 Nov 14

Shingrix Approved for Prevention of Shingles, GSK news release; 2017 Oct 23

More must reads

FDA Actions for September/October 2017

FDA Approves Fast-Acting Mealtime Insulin, Novo Nordisk news release; 2017 Sep 29

FDA Approves FreeStyle Libre System for Adults, FDA news release; 2017 Sep 27

FDA Approves Single Inhaler Triple COPD Therapy, GSK news release; 2017 Sep 18

FDA OKs Diabetes Drug Indication to Reduce CV Risk, Novo Nordisk news release; 2017 Aug 25

More must reads

FDA Actions for July/August 2017

QVAR RediHaler Inhalation Aerosol Approved, Teva Pharmaceutical news release; 2017 Aug 7

FDA Approves Insulia Diabetes Management App, Voluntis news release; 2017 Jul 18

More must reads

FDA Actions for May/June 2017

FDA Warns of Amputation Risk with Canagliflozin, FDA news release; 2017 May 16

Postmarket Safety Events After FDA Approvals, JAMA; 2017 May 9; Downing, Shah, et al

Tymlos Approved for Osteoporosis in Postmenopausal Women, Radius Health news release; 2017 April 28

More must reads